Search research articles
Contact Us
Filters
Showing results (71-80 of 86) with videos related to
Page
of 9
Sort By:
Antimicrobial Agents and Chemotherapy
|
December 20, 2000
Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria
T M Davis, H L Phuong, K F Ilett, et al.
Gut
|
November 21, 1998
Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene
J D Brensinger, S J Laken, M C Luce, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer
M J Fisher, A K Virmani, L Wu, et al.
Oncogene
|
September 12, 2006
Prohibitin, a protein downregulated by androgens, represses androgen receptor activity
S C Gamble, D Chotai, M Odontiadis, et al.
British Journal of Clinical Pharmacology
|
June 26, 2001
Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria
T Q Binh, K F Ilett, K T Batty, et al.
Cancer Research
|
October 19, 2001
Molecular classification of human carcinomas by use of gene expression signatures
A I Su, J B Welsh, L M Sapinoso, et al.
British Journal of Clinical Pharmacology
|
March 10, 1998
A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria
K T Batty, L T Thu, T M Davis, et al.
Human Mutation
|
January 1, 1997
Mutation of hMSH3 and hMSH6 mismatch repair genes in genetically unstable human colorectal and gastric carcinomas
J Yin, D Kong, S Wang, et al.
The American Journal of Pathology
|
July 8, 1999
Origin of microsatellite instability in gastric cancer
K C Halling, J Harper, C A Moskaluk, et al.
The American Journal of Tropical Medicine and Hygiene
|
December 5, 1998
A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria
K T Batty, A T Le, K F Ilett, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 86) with videos related to
Sort By:
Page
of 9
Antimicrobial Agents and Chemotherapy
|
December 20, 2000
Pharmacokinetics and pharmacodynamics of intravenous artesunate in severe falciparum malaria
T M Davis, H L Phuong, K F Ilett, et al.
Gut
|
November 21, 1998
Variable phenotype of familial adenomatous polyposis in pedigrees with 3' mutation in the APC gene
J D Brensinger, S J Laken, M C Luce, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 19, 2001
Nucleotide substitution in the ectodomain of trail receptor DR4 is associated with lung cancer and head and neck cancer
M J Fisher, A K Virmani, L Wu, et al.
Oncogene
|
September 12, 2006
Prohibitin, a protein downregulated by androgens, represses androgen receptor activity
S C Gamble, D Chotai, M Odontiadis, et al.
British Journal of Clinical Pharmacology
|
June 26, 2001
Oral bioavailability of dihydroartemisinin in Vietnamese volunteers and in patients with falciparum malaria
T Q Binh, K F Ilett, K T Batty, et al.
Cancer Research
|
October 19, 2001
Molecular classification of human carcinomas by use of gene expression signatures
A I Su, J B Welsh, L M Sapinoso, et al.
British Journal of Clinical Pharmacology
|
March 10, 1998
A pharmacokinetic and pharmacodynamic study of intravenous vs oral artesunate in uncomplicated falciparum malaria
K T Batty, L T Thu, T M Davis, et al.
Human Mutation
|
January 1, 1997
Mutation of hMSH3 and hMSH6 mismatch repair genes in genetically unstable human colorectal and gastric carcinomas
J Yin, D Kong, S Wang, et al.
The American Journal of Pathology
|
July 8, 1999
Origin of microsatellite instability in gastric cancer
K C Halling, J Harper, C A Moskaluk, et al.
The American Journal of Tropical Medicine and Hygiene
|
December 5, 1998
A pharmacokinetic and pharmacodynamic study of artesunate for vivax malaria
K T Batty, A T Le, K F Ilett, et al.
Page
of 9